Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
For immediate release 27 October 2014 CSL to acquire Novartis influenza vaccine business CSL Limited (ASX:CSL; USOTC:CSLLY) today announced that it has agreed to acquire Novartis’ global influenza vaccine business for
Add to Reading List
Document Date: 2014-10-26 17:33:41
Open Document
File Size: 133,80 KB
Share Result on Facebook
Company
Novartis /
bioCSL /
CSL Limited /
/
Country
Germany /
United States /
Australia /
United Kingdom /
/
Currency
USD /
/
/
Event
M&A /
Conference Call /
/
IndustryTerm
media conference call /
state-ofthe-art manufacturing facilities /
pharmaceutical acquisitions /
manufacturing plants /
/
MedicalCondition
influenza /
/
Person
Paul Perreault /
Natalie de Vane Snr /
/
/
Position
Mark Dehring Head /
Managing Director and Chief Executive Officer /
Chief Executive Officer /
Director Corporate Communications CSL Behring Phone /
global player /
analyst /
Annual General /
/
SocialTag
Health
CSL Behring
Influenza vaccine
CSL Limited
Influenza
Novartis
FluMist
Pandemic
Vaccination
Vaccines